Sharktank's Daymond John recently opened up about his thyroid cancer diagnosis - and how he is happy to have survived due to surgery.
Unfortunately, you often cannot cure cancer in the long run by cutting it out.
This is one of the biggest false beliefs that causes us to rest assured in our current ways, instead of looking into why we developed thyroid cancer and target that in addition to undergoing surgery, yes.
The issue with simply cutting out the thyroid in Daymond's case is that when we get nodules on our thyroid, it is usually correlated with iodine deficiency and heavy metal toxicity - both of which go undetected even at many executive health checkups.
If Daymond does not address these issues, he risks cancer will return elsewhere in the body.
When the inner milieu is cancer friendly (most hormone cancers are related to iodine deficiency by the way), cancer cells will grow in body, regardless of cutting out the organ it first targets.
Read the full article on Daymond John and his secret battle with thyroid cancer here: http://people.com/…/shark-tank-daymond-john-secret-thyroid…/
References:
Lamb MR, Janevic T, Liu X, Cooper T, Kline J, Factor-Litvak P. 2008. Environmental lead exposure, maternal thyroid function, and childhood growth. Environ Res 106(2):195–202.
López CM, Piñeiro AE, Núñez N, Avagnina AM, Villaamil EC, Roses OE. 2000. Thyroid hormone changes in males exposed to lead in the Buenos Aires area (Argentina). Pharmacol Res 42(6):599–602.
Maervoet J, Vermeir G, Covaci A, Van Larebeke N, Koppen G, Schoeters G, et al. 2007. Association of thyroid hormone concentrations with levels of organochlorine compounds in cord blood of neonates. Environ Health Perspect 115:1780–1786.
Mahaffey KR, Clickner RP, Bodurow CC. 2004. Blood organic mercury and dietary mercury intake: National Health and Nutrition Examination Survey, 1999 and 2000. Environ Health Perspect 112:562–570.
Meeker JD, Rossano MG, Protas B, Diamond MP, Puscheck E, Daly D, et al. 2009. Multiple metals predict prolactin and thyrotropin (TSH) levels in men. Environ Res 109(7):869–873.
Miller MD, Crofton KM, Rice DC, Zoeller RT. 2009. Thyroid-disrupting chemicals: interpreting upstream biomarkers of adverse outcomes. Environ Health Perspect 117:1033–1041.
Mori K, Yoshida K, Hoshikawa S, Ito S, Yoshida M, Satoh M, et al. 2006. Effects of perinatal exposure to low doses of cadmium or methylmercury on thyroid hormone metabolism in metallothionein-deficient mouse neonates. Toxicology 228(1):77–84.
Muntner P, Menke A, DeSalvo KB, Rabito FA, Batuman V. 2005. Continued decline in blood lead levels among adults in the United States: the National Health and Nutrition Examination Surveys. Arch Intern Med 165(18):2155–2161.
Lancet Diabetes Endocrinol. 2015 Apr;3(4):286-95.